Paper Details

  1. Home
  2. Paper Details

Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.

Author: AkkermansR, DompelingE, FolgeringH, MolemaJ, van GrunsvenP M, van HerwaardenC L, van SchayckC P, van WeelC

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Adding beclomethasone, 800 micrograms daily, slowed the unfavorable course of asthma or COPD seen with bronchodilator therapy alone. This effect was most evident in asthmatic patients.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To determine if deterioration in patients with asthma or chronic obstructive pulmonary disease (COPD) during bronchodilator therapy could be slowed by additional treatment with an inhaled corticosteroid. DESIGN: A 4-year prospective study. SETTING: Twenty-nine general practices in the c...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.7326/0003-4819-118-10-199305150-00003

データ提供：米国国立医学図書館（NLM）

Slowing the Deterioration of Asthma and COPD

In the realm of respiratory health, managing chronic conditions like asthma and COPD is like navigating a desert landscape, seeking to prevent further deterioration. This study investigates the impact of adding inhaled corticosteroids to bronchodilator therapy for patients with asthma or COPD. The research reveals that adding beclomethasone dipropionate, an inhaled corticosteroid, slowed the deterioration of lung function observed during bronchodilator therapy alone. This finding underscores the importance of early and appropriate treatment for managing these chronic respiratory conditions.

The Importance of Early Intervention

This study highlights the significant benefits of early intervention in managing asthma and COPD. By adding inhaled corticosteroids to bronchodilator therapy, healthcare providers can slow the progression of these diseases, improving patient quality of life and reducing the risk of complications. This proactive approach is like ensuring that a caravan has the necessary supplies to navigate a long and challenging desert journey.

Managing Chronic Respiratory Conditions

The study provides valuable guidance for patients with asthma and COPD. It emphasizes the importance of adhering to prescribed treatment plans and working closely with their healthcare providers to manage their condition effectively. Early intervention and ongoing management can help patients lead a more fulfilling life and minimize the impact of these chronic respiratory conditions.

Dr.Camel's Conclusion

This research underscores the crucial role of early intervention and appropriate management in managing chronic respiratory conditions like asthma and COPD. It's like ensuring that a caravan is well-equipped with the right supplies and guidance to navigate a vast and challenging desert. By understanding the importance of proactive healthcare, we can help patients with asthma and COPD live longer, healthier, and more fulfilling lives.

Date :
  1. Date Completed 1993-05-12
  2. Date Revised 2019-06-19
Further Info :

Pubmed ID

8470851

DOI: Digital Object Identifier

10.7326/0003-4819-118-10-199305150-00003

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.